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Background
Mucosal epithelial cells may play a critical role in main-
taining the balance between tolerance and induction of
IgA response. Current data suggests this homeostatic bal-
ance may be regulated by the production of epithelial pro-
teins, including thymic stromal lymphopoietin (TSLP)
induced through Toll-like receptors. TLR ligands are also
thought to play an important role in the activation induc-
tion of pro- (or anti-) IgA factors by subepithelial den-
dritic cells and B cells including TGF-beta, IL-4 and APRIL.
In this study we have evaluated a broad range of TLR lig-
ands in mucosal cellular models and in human genital tis-
sue explants for the induction of immunomodulatory
cytokines known to influence IgA induction.
Methods
ME180, HT29 and HEC1a cell lines were used as repre-
sentative examples of vaginal and rectal epithelial cells. In
addition both human cervical and penile explants were
used to assess human genital tissue cytokine response to
TLR ligands. Tissue explants and cell lines were exposed to
TLR ligands for 24 hours and supernatants analysed by
Luminex assay.
Results
The profile of cytokine secretion by the different cell lines
and tissue explants tested demonstrated reactogenicity to
a range of TLR candidates. In particular, LPS (TLR4), pep-
tidoglycan (TLR2), Poly I:C (TLR3), Flagellin (TLR5), FSL-
1 (TLR2 and 6) and CpG (TLR9) were all able to induce a
distinct cytokine profile including the induction of pro-
IgA cytokines IL-1-beta GM-CSF and TGF-beta.
Conclusion
Characterization of the cytokine profile induced by the
evaluated TLR ligands in both cellular and human genital
tissue models may be critical to developing mucosal adju-
vants designed to induce and maintain mucosal IgA
responses to HIV. A pilot in vivo study in mice has evalu-
ated their potential for promoting IgA induction when
using mucosal immunization routes.
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